Equity Profile

COO

The Cooper Companies, Inc.

Health CareHealth Care Supplies$13.9B

Jun4Thu

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

The Cooper Companies, Inc. (COO) operates in the health care sector, focusing on health care supplies, particularly in the contact lens and surgical markets....

Key Metrics to Watch

EPS

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

$1.10

Revenue

Total revenue reflects the company's sales performance and market demand for its products, crucial for assessing growth.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

COO Q2-2026 Earnings Preview

Context

Company Snapshot

The Cooper Companies, Inc. (COO) operates in the health care sector, focusing on health care supplies, particularly in the contact lens and surgical markets. As a key player in these areas, the company is influenced by trends in eye care and surgical innovations, making its performance relevant to investors interested in health care advancements.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+38.00%

Avg Stock Reaction

-0.40%

Last Quarter Recap

In Q1-2026, Cooper Companies reported an EPS of $1.18, significantly exceeding the estimate of $1.03, showcasing strong earnings performance. However, the stock declined by 2.17% the following day, indicating market caution despite the positive earnings surprise.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect Cooper Companies to report solid earnings this quarter, with a consensus EPS of $1.10 and revenue of $1.1 billion. The market is closely watching how the company navigates ongoing challenges in the health care sector.

Bull Case

If Cooper Companies can exceed the EPS estimate and show strong revenue growth, it could signal robust demand for its products and a positive outlook for future quarters.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its growth trajectory and market position.

Key Metrics to Watch

EPS

$1.10

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

Revenue

$1.1B

Total revenue reflects the company's sales performance and market demand for its products, crucial for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $1.10?

A beat on EPS would reinforce investor confidence in the company's profitability and growth potential.

What guidance will management provide regarding revenue growth?

Management's outlook on revenue will be crucial for understanding the company's future performance and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Cooper Companies to leverage new product launches, which could drive higher-than-expected revenue growth.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, indicating strong operational performance.

Options pricing suggests a significant move, indicating that traders anticipate volatility that may not align with consensus expectations.

Key Risk

If revenue growth comes in below $1.0 billion, it could challenge the optimistic outlook currently held by analysts.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will set the tone for the company's growth trajectory amidst a competitive health care landscape.

Bull Confirmed If

An EPS of $1.15 or higher would confirm strong earnings momentum.

Bear Confirmed If

An EPS below $1.05 would raise concerns about profitability and growth.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±0.9%

Pricing rich

The options market is pricing in a significant move of over 10%, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±10.4% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

23.8%

Calls (34K)P/C Ratio: 3.83Puts (11K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cooper Companies beats expectations, history suggests the stock could rise by around 0.95% on the first day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further commentary.

Miss

If the company misses earnings expectations, history suggests a potential decline of approximately 0.40% on the first day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand for contact lenses and surgical products.
3Insights into cost management strategies and their effect on profitability.
4Guidance on future revenue expectations and any potential challenges.
5Discussion of competitive pressures in the health care supplies market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jun1

CRDOAMC

Credo Technology Group Holding Ltd

PreviewView

Jun1

HPEAMC

Company Snapshot

The Cooper Companies, Inc. (COO) operates in the health care sector, focusing on health care supplies, particularly in the contact lens and surgical markets....

Key Metrics to Watch

EPS

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

$1.10

Revenue

Total revenue reflects the company's sales performance and market demand for its products, crucial for assessing growth.

$1.1B

Wall Street expectations, options signals, track record, and call prep available with Pro.

COO Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+38.00%

Avg Stock Reaction

-0.40%

Last Quarter Recap

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Cooper Companies can exceed the EPS estimate and show strong revenue growth, it could signal robust demand for its products and a positive outlook for future quarters.

Bear Case

Conversely, if the company fails to meet earnings expectations or provides weak guidance, it could raise concerns about its growth trajectory and market position.

Key Metrics to Watch

EPS

$1.10

Earnings per share is a critical measure of profitability and will indicate how well the company is managing costs and generating income.

Revenue

$1.1B

Total revenue reflects the company's sales performance and market demand for its products, crucial for assessing growth.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $1.10?

A beat on EPS would reinforce investor confidence in the company's profitability and growth potential.

What guidance will management provide regarding revenue growth?

Management's outlook on revenue will be crucial for understanding the company's future performance and market demand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Cooper Companies to leverage new product launches, which could drive higher-than-expected revenue growth.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, indicating strong operational performance.

Options pricing suggests a significant move, indicating that traders anticipate volatility that may not align with consensus expectations.

Key Risk

If revenue growth comes in below $1.0 billion, it could challenge the optimistic outlook currently held by analysts.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will set the tone for the company's growth trajectory amidst a competitive health care landscape.

Bull Confirmed If

An EPS of $1.15 or higher would confirm strong earnings momentum.

Bear Confirmed If

An EPS below $1.05 would raise concerns about profitability and growth.

Pre-Earnings Positioning

Options Market

Implied Move

±10.43%

Historical Avg

±0.9%

Pricing rich

The options market is pricing in a significant move of over 10%, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±10.4% while COO has averaged ±0.9% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.6%

30d HV

23.8%

Calls (34K)P/C Ratio: 3.83Puts (11K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cooper Companies beats expectations, history suggests the stock could rise by around 0.95% on the first day.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further commentary.

Miss

If the company misses earnings expectations, history suggests a potential decline of approximately 0.40% on the first day.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on revenue.
2Management's commentary on market demand for contact lenses and surgical products.
3Insights into cost management strategies and their effect on profitability.
4Guidance on future revenue expectations and any potential challenges.
5Discussion of competitive pressures in the health care supplies market.